Spectrum Pharma (SPPI) – FDA
-
Spectrum Pharma (SPPI) Receives Permanent J-Code for ROLVEDON™ (eflapegrastim-xnst) Injection (J1449) from U.S. Centers for Medicare & Medicaid Services
-
Spectrum (SPPI) de-prioritizes poziotinib after receiving CRL from FDA, shares drop
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SPPI Stock Lookup